FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.
Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
You may have heard in the news that the U.S. Food and Drug Administration will no longer allow the use of FD&C Red Dye No. 3 ...
Professor and Associate Dean for Research, College of Pharmacy, University of South Carolina Red 3 – also called FD&C Red No.